Latest news
April 3, 2024
Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment
June 9, 2023
Nucleai announces strategic collaboration with Mayo Clinic BioPharma Diagnostics
June 5, 2023
Nucleai and Adlai Nortye Partner to Identify and Validate Novel Spatial Biomarkers Across Adlai Clinical Trials
March 22, 2022
Nucleai closes $33 Million Series B financing to advance its spatial biology platform for drug research, Development and diagnostics
September 15, 2021
Nucleai and Jefferson Health Launch a Strategic Collaboration to discover novel Biomarkers
March 16, 2021
Nucleai Partners With Sheba Medical Center’s ARC Innovation Center For a New Strategic Data Collaboration
July 7, 2020
Debiopharm invests in NucleAI– using AI to develop digital pathology biomarkers